期刊文献+

Expression and Clinical Implication of HIF-1α and VEGF-C in Non-small Cell Lung Cancer

Expression and Clinical Implication of HIF-1α and VEGF-C in Non-small Cell Lung Cancer
下载PDF
导出
摘要 To study the expression and implication of HIF-1α and VEGF-C in non-small cell lung cancer (NSCLC) and its relationship with clinical pathological features of NSCLC, immunohisto-chemical SP was used to detect the expression of HIF-1α and VEGF-C proteins in 48 NSCLC tissues and the same para-cancerous tissues. The positive rates of HIF-1α and VEGF-C were 70.8% (34/48) and 68.8% (33/48) respectively. The expression of HIF-1α protein was detected in a significantly greater proportion in NSCLC carcinoma tissues than that in para-cancerous tissues (12.5% and 16.7%, P〈0.05). The positive rates of HIF-1α and VEGF-C were correlated with lymph node metastasis and TNM stage. No relationship was found between the two factors and age, sex, pathological subtypes and histological grades. The positive rates between HIF-1α and VEGF-C were correlated (P〈0.05). HIF-1α and VEGF-C were over-expressed in NSCLC. They may be involved in the carcinogenesis of NSCLC, and play an important role in invasion and metastasis of NSCLC. HIF-1α and VEGF-C work synergically in the process of NSCLC. To study the expression and implication of HIF-1α and VEGF-C in non-small cell lung cancer (NSCLC) and its relationship with clinical pathological features of NSCLC, immunohisto-chemical SP was used to detect the expression of HIF-1α and VEGF-C proteins in 48 NSCLC tissues and the same para-cancerous tissues. The positive rates of HIF-1α and VEGF-C were 70.8% (34/48) and 68.8% (33/48) respectively. The expression of HIF-1α protein was detected in a significantly greater proportion in NSCLC carcinoma tissues than that in para-cancerous tissues (12.5% and 16.7%, P〈0.05). The positive rates of HIF-1α and VEGF-C were correlated with lymph node metastasis and TNM stage. No relationship was found between the two factors and age, sex, pathological subtypes and histological grades. The positive rates between HIF-1α and VEGF-C were correlated (P〈0.05). HIF-1α and VEGF-C were over-expressed in NSCLC. They may be involved in the carcinogenesis of NSCLC, and play an important role in invasion and metastasis of NSCLC. HIF-1α and VEGF-C work synergically in the process of NSCLC.
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2008年第6期674-676,共3页 华中科技大学学报(医学英德文版)
基金 supported by a grant from Hubei Provincial Department of Science and Technology (No. 2004AA-301C97).
关键词 lung neoplasm hypoxia-inducible factor-1α vascular endothelial growth facor-C lung neoplasm hypoxia-inducible factor-1α vascular endothelial growth facor-C
  • 相关文献

参考文献10

  • 1Ziello J E,Jovin I S,Huang Y.Hypoxia-inducible factor(HIF)-1regulatory pathway and its potential for therapeu-tic intervention in malignancy and ischemia[].Yale Journal of Biology and Medicine.2007
  • 2Duyndam M C,van Berkel M P,Dorsman J C et al.Cisplatin and doxorubicin repress vascular endothelial growth factor expression and differentially down-regulate hypoxia-inducible factor I activity in human ovarian can-cer cells[].Biochemical Pharmacology.2007
  • 3Cao,Y.Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis[].Nature Reviews Cancer.2005
  • 4Semenza GL.HIF-1and human disease:one highly involved factor[].Genes and Development.2000
  • 5TAO J,LI T,LI K,et al.Effect of HIF-1 alpha on VEGF-Cinduced lymphangiogenesis and lymph nodes metastases ofpancreatic cancer[].Journal of Huazhong Agricultural University.2006
  • 6Schoppmann SF,,Fenzl A,Sch ind l M,et al.Hypoxia inducib lefactor-1 alpha correlatesw ith VEGF-C expression and lymphangio-genesis in breast cancer[].B reast Cancer Res Treat.2006
  • 7Hockel M,Vaupel P.Tumor hypoxia: Definitions and current clinical,biologic, and molecular aspects[].Journal of the National Cancer Institute.2001
  • 8Wang GL,Semenza GL.Purification and characterization of hypoxia-inducible factor 1[].Journal of Biological Chemistry.1995
  • 9Breier G,,Licht A H,Nicolaus A,Klotzsche A,Wielockx B,Kirsnerova Z.HIF in vascular development and tumour angio- genesis[].Novartis Foundation Symposium.2007
  • 10Kim HJ,Chung H,Yoo YG,et al.Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1 alpha[].Molecular Cancer Research.2007

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部